Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1997 Jun;76(6):526–528. doi: 10.1136/adc.76.6.526

Campylobacter 0:41 isolation in Guillain-Barré syndrome

E Goddard 1, A Lastovica 1, A Argent 1
PMCID: PMC1717211  PMID: 9245852

Abstract

Accepted 15 January 1997


Over a period of 15 months, 17 children were admitted to the Red Cross War Memorial Children's Hospital (RCWMCH) in Cape Town with Guillain-Barré syndrome. Stool specimens were collected from 14 children and campylobacter was isolated from nine. Six of the nine isolates of Campylobacter jejuni were further identified as C jejuni biotype 2, serotype 0:41. This biotype 2, serotype 0:41 has been identified in only 12 of the 7119 campylobacter isolates at the RCWMCH over a 19 year period. Eight of the nine patients with campylobacter isolates and one of five with negative stool cultures required ventilation. Patients with C jejuni biotype 2, serotype 0:41 were ventilated for a mean (SD) of 33.5 (19.4) days, whereas patients with other campylobacter isolates were ventilated for 17.3 (3.8) days. This is the first report of campylobacters of serotype 0:41 in Guillain-Barré syndrome and could reflect a geographical isolation of this strain.



Full Text

The Full Text of this article is available as a PDF (72.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asbury A. K., Cornblath D. R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol. 1990;27 (Suppl):S21–S24. doi: 10.1002/ana.410270707. [DOI] [PubMed] [Google Scholar]
  2. Aspinall G. O., Fujimoto S., McDonald A. G., Pang H., Kurjanczyk L. A., Penner J. L. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect Immun. 1994 May;62(5):2122–2125. doi: 10.1128/iai.62.5.2122-2125.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blaser M. J., Reller L. B. Campylobacter enteritis. N Engl J Med. 1981 Dec 10;305(24):1444–1452. doi: 10.1056/NEJM198112103052404. [DOI] [PubMed] [Google Scholar]
  4. Briscoe D. M., McMenamin J. B., O'Donohoe N. V. Prognosis in Guillain-Barré syndrome. Arch Dis Child. 1987 Jul;62(7):733–735. doi: 10.1136/adc.62.7.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cole G. F., Matthew D. J. Prognosis in severe Guillain-Barré syndrome. Arch Dis Child. 1987 Mar;62(3):288–291. doi: 10.1136/adc.62.3.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. De Bont B., Matthews N., Abbott K., Davidson G. P. Guillain-Barré syndrome associated with Campylobacter enteritis in a child. J Pediatr. 1986 Oct;109(4):660–662. doi: 10.1016/s0022-3476(86)80236-0. [DOI] [PubMed] [Google Scholar]
  7. Enders U., Karch H., Toyka K. V., Michels M., Zielasek J., Pette M., Heesemann J., Hartung H. P. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol. 1993 Aug;34(2):136–144. doi: 10.1002/ana.410340208. [DOI] [PubMed] [Google Scholar]
  8. Fujimoto S., Yuki N., Itoh T., Amako K. Specific serotype of Campylobacter jejuni associated with Guillain-Barré syndrome. J Infect Dis. 1992 Jan;165(1):183–183. doi: 10.1093/infdis/165.1.183. [DOI] [PubMed] [Google Scholar]
  9. Griffin J. W., Li C. Y., Ho T. W., Xue P., Macko C., Gao C. Y., Yang C., Tian M., Mishu B., Cornblath D. R. Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain. 1995 Jun;118(Pt 3):577–595. doi: 10.1093/brain/118.3.577. [DOI] [PubMed] [Google Scholar]
  10. Ho T. W., Mishu B., Li C. Y., Gao C. Y., Cornblath D. R., Griffin J. W., Asbury A. K., Blaser M. J., McKhann G. M. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain. 1995 Jun;118(Pt 3):597–605. doi: 10.1093/brain/118.3.597. [DOI] [PubMed] [Google Scholar]
  11. Kaldor J., Speed B. R. Guillain-Barré syndrome and Campylobacter jejuni: a serological study. Br Med J (Clin Res Ed) 1984 Jun 23;288(6434):1867–1870. doi: 10.1136/bmj.288.6434.1867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Korinthenberg R., Mönting J. S. Natural history and treatment effects in Guillain-Barré syndrome: a multicentre study. Arch Dis Child. 1996 Apr;74(4):281–287. doi: 10.1136/adc.74.4.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kuroki S., Haruta T., Yoshioka M., Kobayashi Y., Nukina M., Nakanishi H. Guillain-Barré syndrome associated with Campylobacter infection. Pediatr Infect Dis J. 1991 Feb;10(2):149–151. doi: 10.1097/00006454-199102000-00014. [DOI] [PubMed] [Google Scholar]
  14. Kuroki S., Saida T., Nukina M., Haruta T., Yoshioka M., Kobayashi Y., Nakanishi H. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues. Ann Neurol. 1993 Mar;33(3):243–247. doi: 10.1002/ana.410330304. [DOI] [PubMed] [Google Scholar]
  15. Mishu B., Ilyas A. A., Koski C. L., Vriesendorp F., Cook S. D., Mithen F. A., Blaser M. J. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome. Ann Intern Med. 1993 Jun 15;118(12):947–953. doi: 10.7326/0003-4819-118-12-199306150-00006. [DOI] [PubMed] [Google Scholar]
  16. Penner J. L., Hennessy J. N., Congi R. V. Serotyping of Campylobacter jejuni and Campylobacter coli on the basis of thermostable antigens. Eur J Clin Microbiol. 1983 Aug;2(4):378–383. doi: 10.1007/BF02019474. [DOI] [PubMed] [Google Scholar]
  17. Rees J. H., Gregson N. A., Griffiths P. L., Hughes R. A. Campylobacter jejuni and Guillain-Barré syndrome. Q J Med. 1993 Oct;86(10):623–634. doi: 10.1093/qjmed/86.10.623. [DOI] [PubMed] [Google Scholar]
  18. Rees J. H., Soudain S. E., Gregson N. A., Hughes R. A. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med. 1995 Nov 23;333(21):1374–1379. doi: 10.1056/NEJM199511233332102. [DOI] [PubMed] [Google Scholar]
  19. Ropper A. H. Campylobacter diarrhea and Guillain-Barré syndrome. Arch Neurol. 1988 Jun;45(6):655–656. doi: 10.1001/archneur.1988.00520300075022. [DOI] [PubMed] [Google Scholar]
  20. Ropper A. H. The Guillain-Barré syndrome. N Engl J Med. 1992 Apr 23;326(17):1130–1136. doi: 10.1056/NEJM199204233261706. [DOI] [PubMed] [Google Scholar]
  21. Skirrow M. B., Benjamin J. Differentiation of enteropathogenic Campylobacter. J Clin Pathol. 1980 Nov;33(11):1122–1122. doi: 10.1136/jcp.33.11.1122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sugita K., Ishii M., Takanashi J., Niimi H., Yuki N. Guillain-Barré syndrome associated with IgM anti-GM1 antibody following Campylobacter jejuni enteritis. Eur J Pediatr. 1994 Mar;153(3):181–183. doi: 10.1007/BF01958981. [DOI] [PubMed] [Google Scholar]
  23. Vriesendorp F. J., Mishu B., Blaser M. J., Koski C. L. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Ann Neurol. 1993 Aug;34(2):130–135. doi: 10.1002/ana.410340206. [DOI] [PubMed] [Google Scholar]
  24. Yuki N., Ichikawa H., Doi A. Fisher syndrome after Campylobacter jejuni enteritis: human leukocyte antigen and the bacterial serotype. J Pediatr. 1995 Jan;126(1):55–57. doi: 10.1016/s0022-3476(95)70500-7. [DOI] [PubMed] [Google Scholar]
  25. Yuki N., Taki T., Inagaki F., Kasama T., Takahashi M., Saito K., Handa S., Miyatake T. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med. 1993 Nov 1;178(5):1771–1775. doi: 10.1084/jem.178.5.1771. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES